title: Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney disease.
abstract: Conditional deletion of Pkd1 in osteoblasts using either Osteocalcin(Oc)-Cre or Dmp1-Cre results in defective osteoblast-mediated postnatal bone formation and osteopenia. Pkd1 is also expressed in undifferentiated mesenchyme that gives rise to the osteoblast lineage. To examine the effects of Pkd1 on prenatal osteoblast development, we crossed Pkd1(flox/flox) and Col1a1(3.6)-Cre mice, which has been used to achieve selective inactivation of Pkd1 earlier in the osteoblast lineage. Control Pkd1(flox/flox) and Pkd1(flox/+), heterozygous Col1a1(3.6)-Cre;Pkd1(flox/+) and Pkd1(flox/null), and homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) and Col1a1(3.6)-Cre;Pkd1(flox/null) mice were analyzed at ages ranging from E14.5 to 8-weeks-old. Newborn Col1a1(3.6)-Cre;Pkd1(flox/null) mice exhibited defective skeletogenesis in association with a greater reduction in Pkd1 expression in bone. Conditional Col1a1(3.6)-Cre;Pkd1(flox/+) and Col1a1(3.6)-Cre;Pkd1(flox/flox) mice displayed a gene dose-dependent decrease in bone formation and increase in marrow fat at 6 weeks of age. Bone marrow stromal cell and primary osteoblast cultures from homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) mice showed increased proliferation, impaired osteoblast development and enhanced adipogenesis ex vivo. Unexpectedly, we found evidence for Col1a1(3.6)-Cre mediated deletion of Pkd1 in extraskeletal tissues in Col1a1(3.6)-Cre;Pkd1(flox/flox) mice. Deletion of Pkd1 in mesenchymal precursors resulted in pancreatic and renal, but not hepatic, cyst formation. The non-lethality of Col1a1(3.6)-Cre;Pkd1(flox/flox) mice establishes a new model to study abnormalities in bone development and cyst formation in pancreas and kidney caused by Pkd1 gene inactivation.
authors.affiliation: Department of Medicine, University of Tennessee Health Science Center, Memphis, United States of America.
authors.forename: Ni
authors.initials: N
authors.lastname: Qiu
authors.forename: Zhousheng
authors.initials: Z
authors.lastname: Xiao
authors.forename: Li
authors.initials: L
authors.lastname: Cao
authors.forename: Valentin
authors.initials: V
authors.lastname: David
authors.forename: Leigh Darryl
authors.initials: LD
authors.lastname: Quarles
mesh_terms: D000818:Animals; D001846:Bone Development; D001851:Bone Diseases, Metabolic / Q000235:genetics* / Q000473:pathology; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D024042:Collagen Type I / Q000235:genetics; D000090602:Collagen Type I, alpha 1 Chain; D004622:Embryo, Mammalian / Q000378:metabolism / Q000473:pathology; D017353:Gene Deletion; D018507:Gene Expression Regulation, Developmental; D019426:Integrases / Q000235:genetics; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D008648:Mesoderm / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D010006:Osteoblasts / Q000378:metabolism / Q000473:pathology; D010012:Osteogenesis; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D007690:Polycystic Kidney Diseases / Q000235:genetics* / Q000473:pathology; D050396:TRPP Cation Channels / Q000235:genetics*
chemical_list: D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D019426:Integrases; D050396:TRPP Cation Channels; C045073:Cre recombinase